Clinical Trial Update: Treatment of Chronic Pain With Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC) [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 study evaluating cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) for chronic widespread pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Cannabidiol (CBD) (cannabidiol)
• Delta-9-tetrahydrocannabinol (THC) (Delta-9-tetrahydrocannabinol)

Snippet

Sponsor: University of Utah | Conditions: Chronic Pain, Widespread | EARLY_Phase 1 | Status: COMPLETED